Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 27Prostatic Neoplasms 5Osteosarcoma 5Neuroendocrine Tumors 5Neoplasms 5Colorectal Neoplasms 5Clear-cell metastatic renal cell carcinoma 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 3Urethral Neoplasms 3Sarcoma, Ewing 3Sarcoma 3Neoplasm Metastasis 3Kidney Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Medullary 3Urogenital Neoplasms 2Ureteral Neoplasms 2Small Cell Lung Carcinoma 2Penile Neoplasms 2Melanoma 2Lung Neoplasms 2Central Nervous System Neoplasms 2Carcinoma 2Adrenocortical Carcinoma 2von Hippel-Lindau Disease 1Wilms Tumor 1Urachal adenocarcinoma 1Triple Negative Breast Neoplasms 1

Interventions

Specimen Handling 4Radiotherapy 4Radiation 4Nivolumab 4pembrolizumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Doxorubicin 3CTLA-4 Antigen 3Biopsy 3talimogene laherparepvec 1peposertib 1pazopanib 1liposomal doxorubicin 1fludarabine 1cabozantinib 1aldesleukin 1X-Rays 1Trabectedin 1Ifosfamide 1Histamine H2 Antagonists 1Famotidine 1Dactinomycin 1Cyclophosphamide 1BO-112 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × cabozantinib × 90 days × Clear all
NCT05836571 2026-04-21

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
66 enrolled
Sarcoma

Sarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡